Preparation of redox-sensitive β-CD-based nanoparticles with controlled release of curcumin for improved therapeutic effect on liver cancer in vitro
详细信息    查看全文
文摘
A redox-sensitive beta-cyclodextrin nanoparticle (β-CD NP) system was prepared for the controlled release of curcumin (CUR), and its therapeutic efficacy on liver cancer was compared with that of CUR in vitro. 1-Dodecanethiol (DDT) was conjugated to per-6-thiol-β-CD by disulfide bond formation though an oxidation reaction (β-CD-ss-DDT). Rhodamine B (RhoB) was included into the β-CD-ss-DDT cavity by inclusion complex formation (β-CD-ss-DDT-ic-RhoB). CUR was encapsulated into β-CD-ss-DDT-ic-RhoB aggregates by self-assembly through dialysis method. The composition, morphology, size distribution and zeta potential of β-CD-ss-DDT-ic-RhoB NPs were characterized by proton nuclear magnetic resonance (1H NMR), Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM) and dynamic light scattering (DLS), respectively. It was found that CUR was released from β-CD-ss-DDT-ic-RhoB/CUR NPs due to the dissociation of β-CD-ss-DDT through a reduction reaction. β-CD-ss-DDT-ic-RhoB/CUR NPs had a higher cellular uptake ratio and a greater anticancer effect on mouse hepatoma Hepa 1-6 cells than CUR, mainly attributed to the improved water-solubility of CUR after encapsulating it in the NPs. Our findings suggest that β-CD-ss-DDT-ic-RhoB NPs can be used as nanocarriers for delivering CUR into cancer cells, thereby serving as a clinical therapeutic agent for liver cancer treatment.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700